Author: therawinformant

  • Could Qube Holdings shares make you rich in 2020?

    Investor in white shirt dreaming of money

    Every investor is on the lookout for bargain buys right now, but one ASX share that I’m not hearing much about is Qube Holdings Ltd (ASX: QUB).

    What does Qube Holdings do?

    Qube is Australia’s largest logistics provider and operates as a specialised integrated port services provider across Australia, New Zealand and South East Asia.

    Qube has over 130 locations and more than 6,500 employees with a market capitalisation of over $5 billion.

    That demonstrates an established (and successful) business to me, but why could Qube shares make you rich in 2020?

    Why Qube Holdings shares could be in the buy zone

    Part of the reason I’m looking at Qube Holdings shares is due to the coronavirus pandemic.

    The shutdowns and border closures related to the pandemic in February and March hit the Qube share price hard.

    In fact, the company’s shares went from a 52-week high to a 52-week low in the space of 2 months. In doing so, Qube’s value per share more than halved to just $1.64 per share.

    While many S&P/ASX 200 Index (INDEXASX: XJO) constituents fell in that bear market, investors wear particularly bearish on logistics. There were concerns that supply chain disruptions would leave logistics providers like Qube without much business in 2020.

    That hasn’t proven to be the case (so far). In fact, Qube Holdings shares have rocketed more than 50% higher since 23 March.

    But I think looking at past growth just isn’t a wise strategy. In my mind, Qube has some huge growth potential as a disruptor in the logistics space.

    I think Qube could be at the forefront of technological change and automation across Australia. That was highlighted to me by the group’s new warehouse automation project with Woolworths Group Ltd (ASX: WOW).

    Woollies and Qube are set to spend at least $1.1 billion on the automated distribution centre in Sydney. Unfortunately, that means jobs are set to go at Woolworths. But what does it mean for Qube?

    I think a strong execution on the Woollies facility could send Qube Holdings’ shares climbing higher in 2020. What’s more, it could be just the first of many automation projects that Qube gets involved in if it continues at its current pace.

    Foolish takeaway

    No one knows what’s ahead for the economy or ASX shares in 2020. However, I like the look of Qube Holdings shares at their current price given what I see as strong growth prospects in the short to medium term.

    3 “Double Down” Stocks To Ride The Bull Market

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon three under-the-radar stock picks he believes could be some of the greatest discoveries of his investing career.

    He’s so confident in their future prospects that he has issued “double down” buy alerts on each of these three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Woolworths Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Could Qube Holdings shares make you rich in 2020? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3fZAqXe

  • Here’s why the Freedom Foods share price will be suspended for 14 days

    No deal

    The Freedom Foods Group Ltd (ASX: FNP) share price won’t be returning to trade any time soon after the diversified food company requested that its shares be suspended for 14 days.

    Freedom Foods made the request while it further investigates its financial position following the sudden exit of its CEO and CFO this month.

    What is happening at Freedom Foods?

    As well as requesting the suspension of its shares, Freedom Foods provided an update on several corporate matters.

    One of these was its inventory position. After writing down the carrying value of its inventory at the end of May by $25 million, the company has been further analysing its stock.

    The company advised that this analysis suggests the need for further write downs to reflect the provisioning for obsolete stock, out of date stock, and product withdrawals. This is expected to lead to an additional write-down of $35 million, bringing the aggregate inventory write down for FY 2020 to ~$60 million.

    Freedom Foods is also looking into inventory held outside the country to see if that needs to be written down.

    In addition to this, the company notes that it has become aware that the initial estimate did not include inventory write-offs related to FY 2020 product withdrawals and deletions and accounting matters relating to costs of goods carried forward as a capital item that should have been included as cost of sales. This matter requires further investigation.

    Doubtful debts.

    Freedom Foods has also been looking into its doubtful debts. It has found that further bad debt provisioning is required and a reversal of prior period revenue recognition will be necessary in FY 2020.

    This is expected to impact its EBITDA by approximately $10 million. Though, the company acknowledged that it may also be necessary to include adjustments to the timing of revenue that was reported in prior periods and debtor balances in the balance sheet.

    And finally, the company has been looking into its employee share plan and found issues. It expects to incur a charge of $5.9 million after the issue of employee options were not completed.

    Foolish Takeaway.

    Overall, this is a very surprising and messy situation financially. Shareholders will no doubt be seeking answers to how this was able to happen.

    3 “Double Down” Stocks To Ride The Bull Market

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon three under-the-radar stock picks he believes could be some of the greatest discoveries of his investing career.

    He’s so confident in their future prospects that he has issued “double down” buy alerts on each of these three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Freedom Foods Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Here’s why the Freedom Foods share price will be suspended for 14 days appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/381NDvQ

  • 5 things to watch on the ASX 200 on Friday

    ASX share

    On Thursday the S&P/ASX 200 Index (ASX: XJO) was out of form and sank notably lower. The benchmark index fell a sizeable 2.5% to 5,817.7 points.

    Will the market be able to bounce back from this on Friday? Here are five things to watch:

    ASX 200 expected to rebound strongly.

    The ASX 200 looks set to finish the week on a high after a strong night of trade on Wall Street. According to the latest SPI futures, the benchmark index is expected to open the day 69 points or 1.2% higher this morning. On Wall Street the Dow Jones rose 1.2%, the S&P 500 climbed 1.1%, and the Nasdaq index also rose 1.1%.

    Bank shares to rise.

    It looks likely to be a better day of trade for Commonwealth Bank of Australia (ASX: CBA) and the rest of the big four banks. This follows a very positive night of trade for U.S. bank stocks, which played a key role in driving the major indices higher. The likes of Bank of America, JPMorgan, Citi, and Wells Fargo all climbed more than 3%.

    Oil prices jump.

    Energy producers Santos Ltd (ASX: STO) and Woodside Petroleum Limited (ASX: WPL) could push higher on Friday after oil prices rebounded. According to Bloomberg, the WTI crude oil price is up 2.8% to US$39.09 a barrel and the Brent crude oil price is 3% higher at US$41.50 a barrel. Better than expected U.S. economic data gave oil prices a boost.

    Qantas $1.9 billion equity raising.

    The Qantas Airways Limited (ASX: QAN) share price could return from its trading halt this morning. The airline operator requested the halt on Thursday while it undertakes a $1.9 billion equity raising. This comprises a $1.4 billion fully underwritten placement to institutional investors and a $500 million share purchase plan. Qantas is raising the funds at $3.65 per share, which represents a 12.9% discount to its last close price.

    Gold price largely flat.

    Gold miners such as Newcrest Mining Limited (ASX: NCM) and Northern Star Resources Ltd (ASX: NST) will be on watch today after the gold price traded mostly flat. According to CNBC, the spot gold price is down ever so slightly to US$1,773.80 an ounce.

    3 “Double Down” Stocks To Ride The Bull Market

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon three under-the-radar stock picks he believes could be some of the greatest discoveries of his investing career.

    He’s so confident in their future prospects that he has issued “double down” buy alerts on each of these three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 5 things to watch on the ASX 200 on Friday appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3fSQTfQ

  • Fed to cap bank dividend payments after completing stress test, COVID analysis

    Fed to cap bank dividend payments after completing stress test, COVID analysisThe Fed will bar big banks from increasing their dividend payments, following the central bank’s annual stress tests that included a “sensitivity” analysis incorporating the impact of the COVID-19 crisis.

    from Yahoo Finance https://ift.tt/2BA6cv7

  • Nike swings to a quarterly loss as global store closures dent results

    Nike swings to a quarterly loss as global store closures dent resultsNike reported fiscal 4Q results after market close Thursday.

    from Yahoo Finance https://ift.tt/2YwVTkn

  • Moderna Partners With Catalent For First 100 Million Covid-19 Vaccine Doses In Q3

    Moderna Partners With Catalent For First 100 Million Covid-19 Vaccine Doses In Q3Moderna Inc. (MRNA) said it entered into a collaboration with Catalent (CTLT) for large-scale, commercial manufacturing of its mRNA-based experimental vaccine candidate against the novel coronavirus.As part of the agreement, Catalent will provide vial filling and packaging, as well as additional staffing at its facility for the production of an initial 100 million doses of the vaccine candidate to supply the U.S. market starting in the third quarter of this year. The companies said that they are also in talks to secure capacity for continued production of hundreds of millions of additional doses.The announcement pushed Catalent shares up 3.2% to $72.71 in midday U.S. trading, while Moderna dropped 5% to $61.60.“We appreciate this collaboration with Catalent and the flexibility of their team to deliver critical fill-finish capacity for mRNA-1273 at unprecedented speed,” said Juan Andres, Moderna’s Chief Technical Operations and Quality Officer.The partnership comes as Moderna announced that it is commencing with the late-stage testing of its COVID-19 vaccine candidate. The biotech company, which has already finalized the Phase 3 study protocol for the vaccine candidate is expected to start a trial of 30,000 participants enrolled in the U.S. in July.The trial’s primary endpoint will be the prevention of symptomatic COVID-19 disease, while key secondary endpoints include prevention of infection by SARS-CoV-2, the virus that causes the disease. As part of the collaboration, Catalent will also provide clinical supply services for the study, including packaging, labeling, storage and distribution.Shares in Moderna more than tripled this year, as investors piled into the stock amid hopes for the potential of its virus vaccine. It looks like the rally has not yet run out of steam. Indeed, the $87.64 average analyst price target still indicates a bullish 43% upside potential from current levels. (See Moderna stock analysis on TipRanks).Five-star analyst Geulah Livshits at Chardan Capital on Thursday reiterated a Buy rating on the stock with a $84 price target.“The disclosed agreement with Catalent puts another piece in place towards Moderna's commercial deployment of mRNA-1273 if positive clinical data emerge,” Livshits wrote in a note to investors.Moderna stock scores 11 Buy ratings versus 2 Hold ratings from analysts which add up to a Strong Buy consensus.Related News: LabCorp Launches Neutralizing Antibody Test For Covid-19 Gilead To Acquire Stake in Cancer Drug Developer Pionyr For $275 Million Merck, BioInvent Enroll First Patient In Solid Tumor Combo Trial More recent articles from Smarter Analyst: * Keysight Buys Eggplant From Carlyle In $330 Million Deal * Amazon Launches New Counterfeit Crimes Unit To Combat Knockoffs * Ally Financial, CardWorks Back Out Of $2.65B Merger Deal Due To Covid-19 * LabCorp Launches Neutralizing Antibody Test For Covid-19

    from Yahoo Finance https://ift.tt/3dD38vn

  • Would a president Joe Biden ruin your stock portfolio?

    Would a president Joe Biden ruin your stock portfolio?It's almost election time…and time to possibly examine your portfolio.

    from Yahoo Finance https://ift.tt/3dFRlgd

  • Cloud computing ETFs soar sky high

    Cloud computing ETFs soar sky highYahoo Finance’s Akiko Fujita and Morningstar’s director for global ETF research Ben Johnson discuss the moves in cloud computing ETFs amid COVID-19.

    from Yahoo Finance https://ift.tt/2VlplrP

  • Rite Aid Asks Bondholders for More Time Amid Tepid Turnaround

    Rite Aid Asks Bondholders for More Time Amid Tepid Turnaround(Bloomberg) — Rite Aid Corp. is asking some of its creditors for a few more years of patience while it tries to turn around the struggling drugstore chain.Bondholders are being asked to swap $750 million of Rite Aid’s unsecured 2023 notes for securities that wouldn’t be paid back for three more years, according to a statement. They’d also have to accept a haircut on their holdings. In return, the new notes would be secured by Rite Aid’s assets and pay a higher interest rate.The debt swap was disclosed as part of a first-quarter earnings release that included a net loss from continuing operations of $72.7 million. Rite Aid withdrew its forecasts, citing effects of the coronavirus pandemic on its business.“Rite Aid’s fiscal 2021 is shaping up to be another challenging year, as it must face lingering structural challenges and pandemic-related shortfalls,” Bloomberg Intelligence analysts Jonathan Palmer and Fallon Stephan wrote in a note prior to the earnings results.Exchange TermsThe proposed swap would exchange the unsecured 2023 notes that pay interest of 6.125% for secured notes that come due in 2026 and pay 8%. Participating bondholders would receive $800 in new notes and $194 in cash for every $1,000 of face value if they tender early.Rite Aid, based in Camp Hill, Pennsylvania, is also asking bondholders for permission to create more secured debt.The drugstore chain has continued to struggle with high leverage tied to its $3.3 billion of debt amid pressure on its pharmacy and retail businesses.While its deal to sell about half of its stores to Walgreens helped reduce debt, Rite Aid has been trying to improve in-store retail sales while also dealing with falling pharmacy revenue due to reimbursement pressure, according to BI.New BossThe company recruited Heyward Donigan, a digital health executive with little retail background, to be its new chief executive and presented a vision for its turnaround in March.“Rite Aid emerged from its asset sale to Walgreens as a smaller competitor with a cleaner, but still highly levered, balance sheet. It faces an uphill climb due to structural conditions as it tries to improve profitability,” Bloomberg Intelligence said in a March note.It benefited from customers stocking up on essential medications and cleaning supplies in anticipation of the Coronavirus shelter-in-place orders, according to the earnings statement. However, many of Rite Aid’s stores are in states that have been hardest hit, according to BI, so the initial burst of purchases may not be sustained as the pandemic drags on.The notes targeted by Rite Aid rose by 3 cents on the dollar to 98 cents, according to Trace bond trading data. Some of its longer-dated unsecured debt hovers around 85 cents. The early tender deadline is July 9 at 5 p.m. New York time. The exchange offer expires July 23 at 11:59 p.m.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    from Yahoo Finance https://ift.tt/2B0G24Y